Randomized Trial of Tamoxifen versus Aminoglutethimide and versus Combined Tamoxifen and Aminoglutethimide in Advanced Postmenopausal Breast Cancer.

Autor: Alonso-Muñoz, M.C., Ojeda-González, M.B., Beltran-Fabregat, M., Dorca-Ribugent, J., López-López, L., Borrás-Balada, J., Cardenal-Alemany, F., Gómez-Batiste, X., Fabregat-Mayol, J., Viladiu-Quemada, P.

Publikováno v: Oncology; 1988, Vol. 45 Issue 5, p350-353, 4p

Fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus FAC followed by weekly paclitaxel as adjuvant therapy for high-risk, node-negative breast cancer: results from the GEICAM/2003-02 study.

Autor: Martín M; Instituto de Investigación Sanitaria Gregorio Marañon, Universidad Complutense, Dr. Esquerdo 46, Madrid 28009, Spain. mmartin@geicam.org, Ruiz A, Ruiz Borrego M, Barnadas A, González S, Calvo L, Margelí Vila M, Antón A, Rodríguez-Lescure A, Seguí-Palmer MA, Muñoz-Mateu M, Dorca Ribugent J, López-Vega JM, Jara C, Espinosa E, Mendiola Fernández C, Andrés R, Ribelles N, Plazaola A, Sánchez-Rovira P, Salvador Bofill J, Crespo C, Carabantes FJ, Servitja S, Chacón JI, Rodríguez CA, Hernando B, Álvarez I, Carrasco E, Lluch A

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2013 Jul 10; Vol. 31 (20), pp. 2593-9. Date of Electronic Publication: 2013 Jun 03.